Investing Profile

Abbie Celniker

InvestorVC
Partner at Third Rock Ventures
Photo of Abbie Celniker, Partner at Third Rock Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
University of California, San Diego Network
118 CONNECTIONS
UC San Diego Network
101 CONNECTIONS
University of California, Davis Network
100 CONNECTIONS
Pfizer Network
77 CONNECTIONS
Novartis Network
74 CONNECTIONS
cb
$100K - $5.0M
$1.5M
6
$770M
CompanyStageDateRound SizeTotal Raised
Flare Therapeutics
Series CJun 2026$85M
Series BMar 2023$120M
Series AMay 2021$82M
$290M
Co-investors: Jakob Loven (Nextech Invest)
Merida Biosciences
Series AApr 2025$120M
SeedJan 2022
$120M
Co-investors: Sherry Chao (GV (Google Ventures)), Andrew Hack (Bain Capital Ventures), Reid Huber (Third Rock Ventures)
Abata Therapeutics
Series AJun 2021$95M
$95M
Co-investors: Richard Ransohoff (Third Rock Ventures)
Associate Director, Biological Assay Development GenentechPresent
Director, Antibody Technologies and Bioanalytical Sciences Genetics InstitutePresent
VP Protein Technologies PfizerPresent
SVP, Pharmacuetical Sciences and Strategy and Operations Genetics InstitutePresent
Global Head of Biologics NovartisPresent
SVP, Translational Medicine Alexion Pharmaceuticals, Inc.Present
CEO Genetics InstitutePresent
Partner Third Rock VenturesPresent
University of California, San Diego Bachelor of Sciences Biology
University of California, Davis Bachelor of Sciences Biology
UC San Diego Bachelor of Sciences Biology
University of Arizona College of Medicine – Tucson PhD Molecular Biology
Sign in with Google →
Sign in with Google →